Clinical Trials on Bladder Cancer TNM Staging Primary Tumor (T) T3B

Total 229 results

Taris Biomedical LLC
Bristol-Myers Squibb

Terminated

Safety and Tolerability of TAR-200 and Nivolumab in Subjects With Muscle-Invasive Bladder Cancer

Bladder Cancer TNM Staging Primary Tumor (T) T2 | Bladder Cancer TNM Staging Primary Tumor (T) T2A | Bladder Cancer TNM Staging Primary Tumor (T) T2B | Bladder Cancer TNM Staging Primary Tumor (T) T3 | Bladder Cancer TNM Staging Primary Tumor (T) T3A | Bladder Cancer TNM Staging Primary Tumor... and other conditions

United States
University of Rome Tor Vergata
University Of Perugia; University of L'Aquila

Completed

Intravesical Adjuvant Electromotive Mitomycin-C (EMDA/MMC)

Bladder Cancer TNM Staging Primary Tumor (T) Ta | Bladder Cancer TNM Staging Primary Tumor (T) T1 | Bladder Cancer Transitional Cell Grade

Italy
Cancer Institute and Hospital, Chinese Academy...
Tianjin Medical University Cancer Institute and Hospital; Sichuan Cancer Hospital...

Unknown

Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma; (IMRT)

Esophageal Neoplasm | Esophageal Cancer TNM Staging Primary Tumor (T) T3 | Esophageal Cancer TNM Staging Primary Tumor (T) T2 | Esophageal Cancer TNM Staging Regional Lymph Nodes (N) N0 | Esophageal Cancer TNM Staging Distal Metastasis (M) M0

China
Samsung Medical Center
National Cancer Center, Korea; Asan Medical Center; Seoul National University... and other collaborators

Recruiting

Clinical Study Evaluating the Proper Surgical Safety Margin for Early Stage Oral Tongue Cancers

Surgery | Tongue Cancer | Squamous Cell Carcinoma | Resection Margin | Tongue Cancer TNM Staging Primary Tumor (T) T1 | Tongue Cancer TNM Staging Primary Tumor (T) T2

Korea, Republic of
The Second Hospital of Shandong University
Shandong Cancer Hospital and Institute; Wuhan YZY Medical Science and Technology...

Unknown

Detection of Circulating Tumor Tells as The Guidance of the Neoadjuvant Chemotherapy of Esophageal Cancer

Esophageal Cancer TNM Staging Primary Tumor (T) T3

China
City of Hope Medical Center

Recruiting

Stomach Cancer Exosome-based Detection (DESTINEX)

Gastric Cancer | Gastric Adenocarcinoma | Gastric Cancer Stage IV | Gastric Neoplasm | Gastric Cancer Metastatic to Lung | Gastric Cancer Stage | Gastric Cancer Metastatic to Liver | Gastric Cancer Stage III | Gastric Cancer Stage II | Gastric Lesion | Gastric Cancer in Situ | Gastric Cancer Stage IIIB | Gastric... and other conditions

United States, Japan
Santo Spirito Hospital, Italy

Unknown

Surgery for Locally Advanced Colon Cancer: is it Worth it? A Multicenter Retrospective Analysis. (LACC)

Malignant Neoplasm of Large Intestine TNM Staging Primary Tumor (T) T4
Seoul National University Hospital

Unknown

Comparison of Two Insertion Technique of I-gel (I-gel90)

Prostate Cancer | Bladder Cancer | Bladder Tumor | Prostate Tumor
IRCCS San Raffaele

Recruiting

Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

Bladder Cancer | Muscle-Invasive Bladder Carcinoma | Radical Cystectomy | Urinary Diversion | Bladder Urothelial Carcinoma | Progression, Disease | Bladder Cancer Stage II | Bladder Cancer Stage IV | Muscle Invasive Bladder Urothelial Carcinoma | Neobladder | Bladder Cancer TNM Staging | Bladder Cancer Stage... and other conditions

Italy
Case Comprehensive Cancer Center

Withdrawn

Continuous Bladder Irrigation Following Transurethral Resection of Bladder Tumors

Non-muscle Invasive Bladder Cancer (NMIBC) | Bladder Tumor (TURBT)

United States
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Medical Imaging in Bladder Tumors by MRI

Magnetic Resonance Imaging | Bladder Tumor

China
Chinese University of Hong Kong

Recruiting

Transurethral Modified En Bloc Resection For Large Bladder Tumours.

Bladder Cancer | Bladder Tumor | Bladder Neoplasm

Hong Kong
Zhejiang University

Completed

Surgery With HIPEC in Treating Patients With a High Risk of Developing Colorectal Peritoneal Carcinomatosis

Peritoneal Carcinomatosis | Malignant Neoplasm of Large Intestine TNM Staging Primary Tumor (T) T4

China
Medical Enterprises Ltd.

Terminated

Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors. (RITE-USA)

Urinary Bladder Cancer | Bladder Cancer | Malignant Tumor of Urinary Bladder | Bladder Neoplasm | Cancer of Bladder | Carcinoma in Situ of Bladder | Bladder Tumors | Cancer of the Bladder | Neoplasms, Bladder | Papillary Carcinoma of Bladder (Diagnosis) | BCG-Unresponsive Bladder Cancer

United States
Peking University First Hospital

Recruiting

Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer

Urinary Bladder Cancer | Bladder Cancer | Bladder Neoplasms | Bladder Tumors | Neoplasms, Bladder

China
Ikena Oncology
Bristol-Myers Squibb

Completed

A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma

Neoplasms | Neoplasm Metastasis | Solid Tumor | Metastatic Cancer | Bladder Cancer | Advanced Solid Tumor | Advanced Cancer | Urothelial Carcinoma Bladder | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Solid Tumor, Adult | Bladder Disease | Solid Carcinoma | Neoplasm Malignant | Neoplasm, Bladder | Locally Advanced... and other conditions

United States
CHU de Reims

Recruiting

Urinary Markers by SpectrosCopy: Diagnostic Aid in oncologY - Application to Urological Cancers (MUSCADE)

Urinary Bladder Tumour

France
H. Lee Moffitt Cancer Center and Research Institute
Johns Hopkins University; National Institutes of Health (NIH)

Withdrawn

Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention

Bladder Cancer | Urothelial Carcinoma | Bladder Tumor

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Completed

High-dose ICE With Amifostine

Sarcoma | Kidney Cancer | Testicular Germ Cell Tumor | Head and Neck Cancer | Ovarian Cancer | Lung Cancer | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Bladder Cancer | Extragonadal Germ Cell Tumor | Carcinoma of Unknown Primary

United States
University Hospital Bispebjerg and Frederiksberg

Unknown

Outpatient PDD Guided Laser Mediated Destruction of Bladder Tumors (LaserIII)

Bladder Cancer

Denmark
Gregers Gautier Hermann

Completed

Diode Laser Treatment of Bladder Tumors

Bladder Cancer

Denmark
Copenhagen University Hospital at Herlev

Unknown

Identifying Methylation Biomarkers for Monitoring Bladder Tumors

Bladder Cancer

Denmark
David D'Andrea

Completed

En-bloc vs Conventional Resection of Primary Bladder Tumor (eBLOC)

Bladder Cancer

Austria
Vitadx
FONDATION FORCE POUR L'INNOVATION ET LA RECHERCHE EN SANTE; SATT Paris Saclay

Completed

Evaluation of Diagnostic Performance of VisioCyt® Test, in Case of Suspicion of Urothelial Bladder Tumors (VISIOCYT 1)

Bladder Cancer

France
Mansoura University

Completed

Laser En Bloc Resection Of Bladder Tumor (HoLERBT) VS. Conventional Transurethral Resection Of Bladder Tumors (cTURBT) (HoLERBT)

Bladder Cancer

Egypt
University Hospital, Rouen

Completed

URO-BCG-4 : Bladder Tumors Immunotherapy

Bladder Cancer

France
Emory University
Olympus

Completed

PlasmaKinetic (PK) Button Vaporization Electrode for Treatment of Bladder Tumors (PK Button)

Bladder Cancer

United States
Tyra Biosciences, Inc

Recruiting

Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations (SURF301)

Solid Tumor | Bladder Cancer | Advanced Solid Tumor | Urothelial Carcinoma | Metastatic Urothelial Carcinoma | Solid Tumor, Adult | FGFR3 Gene Mutation | Urinary Tract Cancer | Locally Advanced Urothelial Carcinoma | Advanced Urothelial Carcinoma | Non-muscle-invasive Bladder Cancer | FGFR3 Gene Alteration | Urinary... and other conditions

Australia, United States, France, Spain
University of Kansas Medical Center

Recruiting

LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors (LaserEn)

Surgery | Bladder Cancer

United States
Bristol-Myers Squibb
Nektar Therapeutics

Completed

A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer

Bladder Cancer | Bladder Tumor | Muscle-Invasive Bladder Cancer

Russian Federation, China, Germany, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Greece, Israel, Mexico, Netherlands, Poland, Spain, United Kingdom
Fundacio Puigvert
KARL STORZ Endoscopy-America, Inc.

Recruiting

En Bloc Bladder Tumor Resection: Prospective Randomized Study

Bladder Cancer | Urothelial Carcinoma Bladder

Spain
NanOlogy, LLC
US Biotest, Inc.

Completed

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

Urologic Neoplasms | Urogenital Neoplasms | Urinary Bladder Cancer | Bladder Cancer | Urothelial Carcinoma | Urologic Cancer | Urinary Bladder Neoplasm | Cancer of the Bladder | Malignant Tumor of the Urinary Bladder

United States
Ankara Training and Research Hospital

Recruiting

Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation

Bladder Cancer | Superficial Bladder Cancer | Tumor Recurrence | Epirubicin Adverse Reaction

Turkey
National Cancer Institute (NCI)

Completed

Decitabine in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific | Recurrent Melanoma | Recurrent Bladder Cancer | Stage IV Bladder Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IV Melanoma | Recurrent Breast Cancer | Stage III Melanoma

United States
Matthew Galsky
Novartis

Terminated

Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors

Bladder Cancer | Solid Tumors

United States
Stanford University
National Cancer Institute (NCI)

Withdrawn

Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer

Prostate Cancer | Bladder Cancer | Kidney Tumor
NanoCarrier Co., Ltd.

Completed

Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer

Solid Tumors

United States, Romania, Italy, Bulgaria, Poland
Processa Pharmaceuticals

Completed

Dose-Finding and Safety Study for Oral Single-Agent to Treat Advanced Malignancies

Solid Tumor | Metastatic Bladder Cancer

United States
Sesen Bio, Inc.

Completed

Study of Vicinium for Treating Patients With Non-Invasive Urothelial Carcinoma In Situ

Urinary Bladder Cancer | Bladder Cancer | Bladder Neoplasms | Bladder Tumors

United States, Canada
Assiut University

Unknown

Skipping BCG for T1a Urinary Bladder Tumor.

Superficial Bladder Cancer t1a
Ain Shams University

Completed

Neutrophils to Lymphocytes Ratio in Predicting the Response to BCG in Non-muscle Invasive Bladder Cancer

Urinary Bladder Cancer | BCG | Urinary Bladder Neoplasm | Non-Muscle Invasive Bladder Urothelial Carcinoma | Trans Urethral Resection of a Bladder Tumor

Egypt
Novartis Pharmaceuticals

Completed

A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies

Advanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 Mutation

France, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
Istari Oncology, Inc.

Active, not recruiting

LUMINOS-103: A Basket Trial Evaluating the Safety and Efficacy of Lerapolturev (PVSRIPO) and Lerapolturev in Combination With Anti-PD-1/L1 Checkpoint Inhibitors in Patients With Advanced Solid Tumors

Solid Tumor | Bladder Cancer | Non-muscle-invasive Bladder Cancer

United States
I.M. Sechenov First Moscow State Medical University

Unknown

Relationship Between Methods of Bladder Tumor Extraction and Local Recurrence Rate

Bladder Cancer

Russian Federation
Bakirkoy Dr. Sadi Konuk Research and Training Hospital

Not yet recruiting

The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder Cancer

Self Efficacy | Smoking Behaviors | Progression, Disease | Non-Muscle Invasive Bladder Cancer | Tumor Recurrence

Turkey
University Hospital, Toulouse
Institut Claudius Regaud

Recruiting

Induction Chemotherapy Followed by Standard Therapy in Cervical Cancer With Aortic Lymph Node Spread (ONCOCOL01)

Cervical Cancer TNM Staging Regional Lymph Nodes (N)

France
Leslie Ballas

Not yet recruiting

Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology

Muscle-Invasive Bladder Carcinoma | Tumor

United States
Istituto Clinico Humanitas

Unknown

Expression of Markers Related to Mitochondrial Functionality in Carcinoma of the Urinary Bladder: Comparative Retrospective Analysis Between Recurrent Tumors ("Non-responders") and Non-recurrent Tumors ("Responders") After Intravesical Treatment With Chemotherapy or Immunotherapy (MITOMARKER-MIM)

Bladder Cancer

Italy
Mansoura University

Unknown

Role of 3 Tesla Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) for Diagnosis Bladder Cancer Grade and Stage

Bladder Cancer | Magnetic Resonance Imaging | Diagnoses Disease | Apparent Diffusion Coefficient

Egypt
Chinese University of Hong Kong

Recruiting

The Global En Bloc Resection of Bladder Tumour Registry

Bladder Cancer

Hong Kong

Clinical Trials on Bladder Cancer TNM Staging Primary Tumor (T) T3B

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations